Cellevate AB is an innovative biotech company based in Lund, Sweden, that is revolutionizing the field of cell culture systems. With a focus on upstream bioprocessing, they develop the next generation of highly porous and consistent networks of nanofibers through their patented manufacturing process. Cellevate's flagship product platform, Cellevat3d™, provides access to a new dimension of upstream bioprocessing, from research and development to large-scale manufacturing.

This scalable and versatile nanotechnology platform aims to deliver better, faster, and more sustainable biopharmaceuticals at a lower cost. The company is driven by a strong set of core values. They consider themselves champions of a better way in biopharmaceutical manufacturing, challenging legacy technology to lead the way in next dimension upstream bioprocessing.

With cutting-edge expertise in bioprocess engineering and nanotechnology, they strive for perfection and professionalism in all aspects of their work. Cellevate's ultimate goal is to contribute to a more sustainable future by revolutionizing biopharmaceutical manufacturing, reducing costs, increasing yields, and improving the quality of life for people around the world